ACCESSION: MSBNK-SMB_Measured-HSA001P0186016
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.14, Processed 2025.02.21, Annotated 2025.04.02, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Shin-MassBank project in preparation
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MB-POST
COMMENT: DATASET_ID MPST000004
COMMENT: DATASET_TITLE Annotation of various metabolites in SRM 1950 human serum
COMMENT: DATASET_AUTHORS Masatomo Takahashi, Yoshihiro Izumi, Kyushu University
COMMENT: MS1_M/Z_AVERAGED_THRES 0.750
COMMENT: MS2_M/Z_AVERAGED_THRES 4.000
COMMENT: DATASET_FILE_NUM 22
COMMENT: NUM_AVERAGED_SPEC 35
COMMENT: RAW_SPEC {'6_posi_2610': {'bp': 253407.0, 'sum': 723188.0}, '3_posi_2728': {'bp': 181725.0, 'sum': 555113.0}, '4_posi_2539': {'bp': 209259.0, 'sum': 606671.0}, '7_posi_2476': {'bp': 213324.0, 'sum': 687288.0}, 'ProcedureBlank_2603': {'bp': 230140.0, 'sum': 745126.0}, '3_posi_2582': {'bp': 246890.0, 'sum': 739317.0}, '11_posi_2750': {'bp': 183373.0, 'sum': 560981.0}, '13_posi_2939': {'bp': 159642.0, 'sum': 513068.0}, '17_posi_2655': {'bp': 196811.0, 'sum': 600307.0}, '19_posi_2737': {'bp': 213859.0, 'sum': 573323.0}, '2_posi_2519': {'bp': 237289.0, 'sum': 696703.0}, '16_posi_2792': {'bp': 138934.0, 'sum': 402946.0}, '13_posi_2319': {'bp': 144057.0, 'sum': 647041.0}, '7_posi_2771': {'bp': 177406.0, 'sum': 488860.0}, 'ProcedureBlank_2791': {'bp': 182928.0, 'sum': 636737.0}, '13_posi_2498': {'bp': 219457.0, 'sum': 648509.0}, 'BLK02_2705': {'bp': 246541.0, 'sum': 787045.0}, 'ProcedureBlank_2253': {'bp': 144940.0, 'sum': 638128.0}, '11_posi_2279': {'bp': 152810.0, 'sum': 697448.0}, '19_posi_3031': {'bp': 181786.0, 'sum': 600812.0}, '18_posi_2698': {'bp': 194900.0, 'sum': 585547.0}, '14_posi_2561': {'bp': 207694.0, 'sum': 558694.0}, '11_posi_2611': {'bp': 218586.0, 'sum': 671899.0}, '15_posi_2581': {'bp': 220720.0, 'sum': 641997.0}, '7_posi_2275': {'bp': 164604.0, 'sum': 710641.0}, '14_posi_2749': {'bp': 179432.0, 'sum': 540306.0}, '9_posi_2613': {'bp': 208916.0, 'sum': 604519.0}, '9_posi_2296': {'bp': 145284.0, 'sum': 606015.0}, '12_posi_2729': {'bp': 168405.0, 'sum': 528498.0}, '6_posi_2750': {'bp': 158841.0, 'sum': 484636.0}, '4_posi_2729': {'bp': 159518.0, 'sum': 497223.0}, '8_posi_2610': {'bp': 196893.0, 'sum': 585584.0}, '13_posi_2582': {'bp': 239944.0, 'sum': 698488.0}, 'BLK02_2432': {'bp': 221646.0, 'sum': 749759.0}, '17_posi_2561': {'bp': 177554.0, 'sum': 535238.0}}
COMMENT: RETENTION_TIME_STDEV 0.364
COMMENT: PRECURSOR_M/Z_RAW 186.123383
COMMENT: PRECURSOR_M/Z_STDEV 0.000051
COMMENT: PRECURSOR_IN_MS1 mz 186.123689; int 56.137; delta(ppm) 0.969215
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.059; C8H15N3O2; [M+H]+; delta(ppm) -0.059422
COMMENT: PROPOSED_MF MS-FINDER 4.039; C8H15N3O2; [M+H]+; delta(ppm) -0.060049
COMMENT: PROPOSED_MF SIRIUS5_Sirius 27.766; C8H15N3O2; [M+H]+; delta(ppm) -0.060049
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C8H15N3O2; [M+H]+; delta(ppm) -0.060049
COMMENT: PROPOSED_MF SIRIUS6_Sirius 44.130; C8H15N3O2; [M+H]+; delta(ppm) -0.060049
COMMENT: PROPOSED_MF SIRIUS6_Sirius 25.830; C10H17O3; [M+H]+; delta(ppm) -7.273821
COMMENT: PROPOSED_MF SIRIUS6_Sirius 12.568; C6H13N6O; [M+H]+; delta(ppm) 7.153826
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C8H15N3O2; [M+H]+; delta(ppm) -0.060049
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.409; SBYAVOHNDJTVPA-UHFFFAOYSA-N; [M+H]+; CC(C)CNC(=O)N1CCNC1=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.348; OGQVYQIZUYYYKI-UHFFFAOYSA-N; [M+H]+; O=C1NC(C(=O)NC1)CCCCN
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.210; RHLDHAUSBAYWCB-UHFFFAOYSA-N; [M+H]+; O=C(NC)NCCN1C(=O)CCC1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.192; JMTIWTZWNXVIJD-UHFFFAOYSA-N; [M+H]+; CC(=C)C(=O)OCCCN=C(N)N
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.304; OGQVYQIZUYYYKI-UHFFFAOYSA-N; [M+H]+; cyclo(gly-lys)
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.190; SBYAVOHNDJTVPA-UHFFFAOYSA-N; [M+H]+; Isocarbamid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.109; RHLDHAUSBAYWCB-UHFFFAOYSA-N; [M+H]+; 3-methyl-1-[2-(2-oxopyrrolidin-1-yl)ethyl]urea
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.859; JMTIWTZWNXVIJD-UHFFFAOYSA-N; [M+H]+; 3-(diaminomethylideneamino)propyl 2-methylprop-2-enoate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; RHLDHAUSBAYWCB-UHFFFAOYSA-N; [M+H]+; 3-methyl-1-[2-(2-oxopyrrolidin-1-yl)ethyl]urea
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.894; OGQVYQIZUYYYKI-UHFFFAOYSA-N; [M+H]+; cyclo(gly-lys)
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.865; SBYAVOHNDJTVPA-UHFFFAOYSA-N; [M+H]+; Isocarbamid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.343; JMTIWTZWNXVIJD-UHFFFAOYSA-N; [M+H]+; 3-(diaminomethylideneamino)propyl 2-methylprop-2-enoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.901; SBYAVOHNDJTVPA-UHFFFAOYSA-N; [M+H]+; N-(2-methylpropyl)-2-oxoimidazolidine-1-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.475; FUPIHZLHPHQVJZ-UHFFFAOYSA-N; [M+H]+; 1,2-di(propan-2-yl)-1,2,4-triazolidine-3,5-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.641; UWPFRDXXVMXESX-UHFFFAOYSA-N; [M+H]+; 2-(2-oxoazepan-1-yl)acetohydrazide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.250; QTEALOUTOWDNKA-UHFFFAOYSA-N; [M+H]+; 3-[3-(dimethylamino)propyl]imidazolidine-2,4-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.208; RXGHBXDLEQVZFB-UHFFFAOYSA-N; [M+H]+; 3-(3-aminopropyl)-5,5-dimethylimidazolidine-2,4-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.972; MIFFPKWNFPTHND-UHFFFAOYSA-N; [M+H]+; N-[1-[(E)-N'-hydroxycarbamimidoyl]cyclopentyl]acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.843; ILLMBMCUEZSIGD-UHFFFAOYSA-N; [M+H]+; ethyl 2-amino-4,5,6,7-tetrahydro-1H-1,3-diazepine-7-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.842; UAJPOVRGHHNUBW-UHFFFAOYSA-N; [M+H]+; 2-[[2-(cyclopropylamino)-2-oxoethyl]amino]-N-methylacetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.657; XWAQCKUMXUNYHW-UHFFFAOYSA-N; [M+H]+; 1-[3-(1-ethoxyethyl)-1,2,4-oxadiazol-5-yl]-N-methylmethanamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -202.793; UAJPOVRGHHNUBW; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -249.987; RHLDHAUSBAYWCB; [M+H]+; 1-methyl-3-[2-(2-oxopyrrolidin-1-yl)ethyl]urea
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -265.857; VRSAQOMEXLWLBL; [M+H]+; 1-Acetyl-2,6-dimethyl-4-nitrosopiperazine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -270.818; SBYAVOHNDJTVPA; [M+H]+; Isolamid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -311.621; VRDJHWPWOGKRMU; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -336.664; FUPIHZLHPHQVJZ; [M+H]+; Abbott
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.087; UAJPOVRGHHNUBW; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -210.268; ILALABPIKINZAM; [M+H]+; 7-(2-Nitro-ethyl)-azepan-(2Z)-ylideneamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -232.201; UAJPOVRGHHNUBW; [M+H]+; N-Cyclopropyl-2-((2-(methylamino)-2-oxoethyl)amino)acetamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -254.109; FUPIHZLHPHQVJZ; [M+H]+; Abbott
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -255.652; VRSAQOMEXLWLBL; [M+H]+; 1-Nitroso-4-acetyl-3,5-dimethylpiperazine, cis-
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -273.170; SBYAVOHNDJTVPA; [M+H]+; Isocarbamid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -276.982; JMTIWTZWNXVIJD; [M+H]+; 3-(Diaminomethylideneamino)propyl 2-methylprop-2-enoate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -278.785; VRDJHWPWOGKRMU; [M+H]+; 2,2,5,5-Tetramethyl-3-hydrazono-4-(hydroxyimino)tetrahydrofuran
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -299.834; RHLDHAUSBAYWCB; [M+H]+; 3-methyl-1-[2-(2-oxopyrrolidin-1-yl)ethyl]urea
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -307.866; MIFFPKWNFPTHND; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -322.105; XDCKHCPSQTVMKR; [M+H]+; cimipronidine methyl ester
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.087; ILALABPIKINZAM; [M+H]+; 7-(2-Nitro-ethyl)-azepan-(2Z)-ylideneamine
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C8H16N3O2; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(1), SIRIUS5_Sirius(1), SIRIUS5_Zodiac(1);
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Serum
AC$INSTRUMENT: Nexera X2 UHPLC system, Shimadzu - Q Exactive Orbitrap, Thermo Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 20 V
AC$MASS_SPECTROMETRY: COLLISION_GAS N2
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 0.75; MS2(ppm) 4.00
AC$CHROMATOGRAPHY: COLUMN_NAME GL-HilicAex 2.1 x 150 mm, 5 mm (Resonac)
AC$CHROMATOGRAPHY: FLOW_GRADIENT B conc(%). 0 min: 95, 0.5 min: 95, 15.5 min: 40, 16.5 min: 0, 26.5 min: 0, 27.5 min: 95, 35 min: 95.
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 5.232
MS$FOCUSED_ION: PRECURSOR_M/Z 186.123692
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-000i-1900000000-c58eb45b18c2255d0991
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  71.0603368 34.6011 71.060950 1.0132 9.69 0.4833 33 f{C3H7N2}/-0.53ppm,p-C5H9N1O2
  72.0443035 65.5728 72.044910 1.0688 26.62 0.0754 35 f{C3H6N1O1}/-1.20ppm,p-C5H10N2O1
  86.0600533 244.6030 86.060520 0.5113 47.27 0.4493 35 f{C4H8N1O1}/0.15ppm,p-C4H8N2O1
  101.0709619 30.5070 101.071275 2.3251 10.14 0.0188 26 f{C4H9N2O1}/0.22ppm,p-C4H7N1O1
  115.0866296 50.1409 115.086800 1.6857 26.39 0.0871 35 f{C5H11N2O1}/0.35ppm,p-C3H5N1O1
  116.0900075 34.9680 116.090166 2.3516 16.52 0.0901 30 ?
  126.1025932 87.8575 126.102620 1.3798 15.62 0.7084 35 f{C6H12N3}/0.15ppm,p-C2H4O2
  127.0866774 150.5051 127.086690 0.9521 34.97 0.3821 35 f{C6H11N2O1}/0.69ppm,p-C2H5N1O1
  140.1182258 307.8588 140.118130 0.6352 71.96 0.7361 35 f{C7H14N3}/0.01ppm,p-C1H2O2
  141.1023064 74.4532 141.102210 1.7576 20.35 0.5951 34 f{C7H13N2O1}/0.47ppm,p-C1H3N1O1
  145.0858990 91.7605 145.085800 1.3578 36.62 0.0633 35 ?
  158.1289174 70.0725 158.128810 1.5936 12.76 0.7006 35 f{C7H16N3O1}/0.81ppm,p-C1O1
  168.1131838 179.8370 168.113070 0.8744 19.36 0.7980 35 f{C8H14N3O1}/0.27ppm,p-H2O1
  169.0971644 217.0582 169.097050 0.7747 111.16 0.1190 35 f{C8H13N2O2}/0.06ppm,p-H3N1
  186.0882452 74.6854 186.088120 2.3752 45.80 0.1703 35 ?
  186.1239552 999.0000 186.123830 0.6179 0.00 1.0000 35 f{C8H16N3O2}/1.35ppm,p
  186.1428852 201.7956 186.142760 1.0207 87.98 0.0630 35 ?
PK$NUM_PEAK: 17
PK$PEAK: m/z int. rel.int.
  71.060337 34.60 34
  72.044303 65.57 65
  86.060053 244.60 244
  101.070962 30.51 30
  115.086630 50.14 50
  116.090008 34.97 34
  126.102593 87.86 87
  127.086677 150.51 150
  140.118226 307.86 307
  141.102306 74.45 74
  145.085899 91.76 91
  158.128917 70.07 70
  168.113184 179.84 179
  169.097164 217.06 217
  186.088245 74.69 74
  186.123955 999.00 999
  186.142885 201.80 201
//
